Distinct Expression of Cytokeratin, N-Cadherin and CD133 in Circulating Tumor Cells of Metastatic Breast Cancer Patients

Carolin Bock, Brigitte Rack, Jens Huober, Ulrich Andergassen, Udo Jeschke, Sophie Doisneau-Sixou

Future Oncology · 2014 · 24 citations · 45 references

Concepts

Abstract

AIM: Circulating tumor cells (CTCs) appear as potential candidates to predict the ability of breast tumors to metastasize. Moreover, epithelial-mesenchymal transition (EMT) and stem cell features are major mechanisms for metastasis. PATIENTS & METHODS: Using a triple fluorescence technique, the expression of EMT (N-cadherin) and stem cell markers (CD133) was analyzed in CTCs detected via cytokeratin in blood samples from 26 metastatic breast cancer patients. RESULTS: We detected CTCs in 100% of the patients (n = 831 CTCs). In total, 67% of the CTCs were N-cadherin and CD133 negative. Nonetheless, 87.8 and 57.6%, respectively, of the CTCs that expressed one marker coexpressed the other. Both double-negative and double-positive CTCs were present in more than 90% of the patients. Within the CTCs of each patient, we demonstrated striking heterogeneities of marker expressions, cell shapes, clusters and sizes. CONCLUSION: These data outline the importance of characterizing CTCs, especially through stem cell and EMT markers.

References

45